Companies 0 See All

Hedge Funds 0 See All

Insiders 0 See All

Institutional Investors 0 See All

Click here to see all results for

Home > Insider Trading > Filing (0001477932-23-006213)

Filing Details

Accession Number:: 0001477932-23-006213
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2023-08-16 12:28:46
Reporting Period:: 2023-08-16

Accepted Time:: 2023-08-16 12:28:46
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
93314	Volitionrx Ltd	VNRX	In Vitro & In Vivo Diagnostic Substances (2835)	911949078

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1340610	John Cameron Reynolds	1489 West Warm Springs Road Suite 110 Henderson NV 89014	President And Ceo	No	No	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2023-08-16	10,000	$1.22	1,494,518	No	4	P	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	P	Direct

Reported Non-Derivative Holdings

Sec. Name	Remaning Holdings	Nature of Ownership	Explanation
Common Stock	1,007,718	Indirect	By Concord International, Inc.
Common Stock	34,076	Indirect	By Spouse

Footnotes

The shares of common stock are held directly by Concord International, Inc. Mr. Reynolds is the majority shareholder of Concord International, Inc. and shares voting and dispositive control over the shares of common stock held by Concord International, Inc.